thirty-one out-patients with rheumatoid arthritis took part in a 10 week double-blind comparison of sulindac ( cis-5-fluoro-2-methyl-1- [ p- ( methylsulphinyl ) -benzylidene ] -indene-3-acetic acid ) 200 mg twice daily and aspirin 3.6 g daily , with a 2-week placebo control period .
C0003873
rheumatoid arthritis
C0038792
sulindac